Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07789678 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07789678 · ClinicalTrials.gov record · last posted 2026-08-27

A Single-arm Observational Study to Characterize the Epidemiological Profile of Patients With IDH-mutant Diffuse Gliomas Diagnosed From 2021 in Brazil.

Study acronym: BRIGHT
StatusNot Yet Recruiting
PhaseNot specified
Started2026-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a real-world, retrospective, non-interventional, single-arm, multi-center Brazilian study that will include patients diagnosed with IDH-mutant diffuse glioma in Brazil from 2021. Eligible patients will be included in this study to have their medical charts data collected by site personnel. Included patients won´t be requested to attend protocol-specific visits and treatment decisions and disease management will be at the investigator's discretion
Trial Details
NCT Number NCT07789678
Lead Sponsor Latin American Cooperative Oncology Group
Conditions Diffuse Glioma, IDH-mutant Gliomas
Enrollment 350 participants
Start Date 2026-09
Primary Completion 2027-03 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-27